|
TPMT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.300180E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.670190E-02 |
| Normal-vs-Stage2 |
6.681500E-02 |
| Normal-vs-Stage3 |
4.179100E-03 |
| Normal-vs-Stage4 |
2.123200E-03 |
| Stage1-vs-Stage2 |
9.885000E-01 |
| Stage1-vs-Stage3 |
1.773440E-01 |
| Stage1-vs-Stage4 |
4.414400E-02 |
| Stage2-vs-Stage3 |
3.452600E-01 |
| Stage2-vs-Stage4 |
1.892590E-01 |
| Stage3-vs-Stage4 |
6.186600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.512420E-02 |
| Normal-vs-AfricanAmerican |
1.030280E-02 |
| Normal-vs-Asian |
4.127700E-02 |
| Caucasian-vs-AfricanAmerican |
9.222600E-01 |
| Caucasian-vs-Asian |
3.802200E-01 |
| AfricanAmerican-vs-Asian |
3.455600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.778500E-02 |
| Normal-vs-Female |
3.626000E-04 |
| Male-vs-Female |
1.269890E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.021700E-04 |
| Normal-vs-Extreme_Weight |
9.317400E-03 |
| Normal-vs-Obese |
5.088200E-02 |
| Normal-vs-Extreme_Obese |
5.475400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.924970E-01 |
| Normal_Weight-vs-Obese |
1.022010E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.001700E-02 |
| Extreme_Weight-vs-Obese |
5.894400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.998400E-01 |
| Obese-vs-Extreme_Obese |
4.943600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.218000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.019700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.146500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.627620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.632000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.484000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.261700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.041400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.936400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.741600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.171000E-01 |
| Normal-VS-Type2 PRCC |
3.675100E-03 |
| Normal-VS-KIRP CIMP |
5.0354165281874E-12 |
| Normal-VS-Unclassified PRCC |
1.243400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.361090E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.15685239165941E-13 |
| Type1 PRCC-VS-Unclassified PRCC |
2.198600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.70189995008752E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
6.648400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.48829999999401E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.660700E-03 |
| Normal-vs-N1 |
9.53870000000023E-05 |
| Normal-vs-N2 |
5.682700E-03 |
| N0-vs-N1 |
2.041400E-01 |
| N0-vs-N2 |
1.719360E-01 |
| N1-vs-N2 |
3.113800E-01 |
|
|
